While automation is becoming part of the intake process, most pharmacovigilance teams still rely on a combination of automated workflows and manual review to assess, classify and route each case. This webinar explores how AI-enabled adverse event detection and intake can help teams manage this increasing volume while maintaining appropriate human oversight.
As data volumes grow, hybrid processes can create delays, increase workload and introduce inconsistency, making it difficult to scale efficiently without compromising quality. The opportunity is to automate case intake where appropriate, while preserving the human oversight needed for complex decisions. The result is a more efficient, consistent, scalable and quality-focused pharmacovigilance process.
The session will examine practical considerations for introducing AI into a regulated pharmacovigilance environment, including embedded quality checks, transparent confidence indicators, auditability and end-to-end traceability of extracted information and resulting decisions. The goal is not to replace human oversight but to automate appropriate activities and focus expert attention where it adds the most value.
A live demonstration of ElevateSafety™ and Detective will illustrate how AI-enabled detection, data structuring, quality checks and routing can support adverse event intake across diverse data sources. Whether an organization is evaluating AI for the first time or benchmarking an existing approach, this session will provide a practical, grounded view of what’s possible today for pharmaceutical and life sciences safety operations.
Register for this webinar to learn how pharmacovigilance teams can use AI to manage rising data volumes without sacrificing quality, compliance or human accountability.
Speaker
Cyle Connell, Senior Manager, Deloitte Consulting LLP
Cyle Connell has extensive experience leading global, cross-functional teams through successful software implementations and business process transformations, including ElevateSafety™ and Deloitte. He enjoys diving into technical details and adding value in all areas.
Message PresenterWho Should Attend?
This webinar will appeal to:
- Pharmacovigilance and Drug Safety professionals
- Case Processing and Intake teams
- Regulatory Affairs professionals
- Quality Assurance & Compliance professionals
- Patient Safety leaders
- AI and Digital Innovation teams in life sciences
What You Will Learn
Attendees will gain insight into:
- How AI can detect, classify and route adverse events and product quality complaints across diverse, high-volume data sources
- How confidence-based classification helps teams focus human attention on cases that require expert review rather than routine manual triage
- What guardrails make AI adoption viable in a regulated pharmacovigilance environment
- What AI-enabled detection and intake looks like in practice, demonstrated live
Xtalks Partner
Deloitte
Converge™ by Deloitte engineers the future of life sciences by combining our leading industry specialists with technology alliances and proprietary data, workflow, AI, and cloud software solutions. Powered by continual innovation and an industry-first mindset, we help our clients purposefully connect and advance the business of life sciences across R&D, supply chain and manufacturing, cell and gene orchestration, and commercialization, assisting companies to accelerate their journey to differentiation.
You Must Login To Register for this Free Webinar
Already have an account? LOGIN HERE. If you don’t have an account you need to create a free account.
Create Account